Stock Up More ARVs To Combat Coronavirus- Gvt Told

THE Community Working Group on Health (CWGH) Executive Director, Mr Itai Rusike has urged government to mobilse enough financial resources to procure Kaletra, an Antiretroviral (ARV) drug that has proven effective in treating Coronavirus (COVID-19) as part of its preparedness to deal with the deadly bug. By Michael Gwarisa The disease has hit at least 70 countries, with 90,000 cases and 3,100 deaths. The vast majority of cases and deaths have been in China. While the number of new cases recorded daily in that epicenter country has declined for weeks,…

Share
Read More

Zimbabwe To Use ARVs To Treat Coronavirus

THE Zimbabwean government is upbeat about its preparedness levels against the Coronavirus disease 2019 (COVID 19) saying antiretroviral medicines used elsewhere for the recovery of patients are in full stock. By Kudakwashe Pembere In an interview with HealthTimes on Tuesday, Health and Child Care Minister Dr Obadiah Moyo said Zimbabwe has fully stocked with the antiretroviral drug reportedly being used in the recovery of patients confirmed to have coronavirus. “We have Kaletra and we are hearing reports that it is helping a lot. They then use it in combinations with…

Share
Read More

ARV Stock-outs: More People Miss Doses In Chipinge

CHIPINGE recorded the highest number of households with members who missed Antiretroviral Treatment (ART) doses since beginning of the year 2019 at the back of drug stock outs amongst a host of other factors. By Michael Gwarisa Medicines stock-outs as for the period under review stood at 28% and was reported as the major reason for people missing ART doses while failure to access  health facilities  was at 20.9%, inadequate transport money to travel to health facilities 10.4% and forgetting to take medication by  members living with HIV 10.4%. According…

Share
Read More

Zimbos Now Buying ARVs In Zambia

PEOPLE Living With HIV have resorted to buying Antiretroviral drugs from neighboring Zambia amidst fears of developing side effects from the expired stocks currently being dispensed in some health institutions. By Kudakwashe Pembere & Michael Gwarisa This is despite the assurance from the Medicines Control Authority of Zimbabwe (MCAZ) that the medicines have been tested and certified safe for consumption by people living with HIV. Speaking to HealthTimes on the sidelines of a march against ARV stock-outs,  Gumisai Bonzo a women living with HIV said they have organised groups to…

Share
Read More

Parliament Petitioned Over ARV Shortages

PEOPLE Living With HIV (PLHIV) have handed over a petition to the Parliament of Zimbabwe in a bid to push government to urgently allocate financial resources to arrest the prevailing drug shortage before the situation goes out of hand. By Michael Gwarisa The development comes at the back of indications that the National Aids Council (NAC) is sitting on a cash pile of RTGS$20 million which they are failing to convert to United States (US) dollars needed to procure drugs from source markets. In an interview on the side-lines of…

Share
Read More

Is NAC On Autopilot?

IT’S been three months since Health and Child Care Minister, Dr Obadiah Moyo dismissed the whole National Aids Council (NAC) board over its failure to turn around fortunes of the organisation. By Michael Gwarisa Not only is NAC running without a board but the organisation has no substantive Chief Executive Officer (CEO) in place. Currently, Mr Raymond Yekeye the Operations Director has been CEO on an acting capacity  for the past six months now. As a news publication, we have made countless efforts to contact the Minster regarding the NAC…

Share
Read More

People Living With HIV To March Against ARV Stock outs

CIVIC Society Organisations (CSOs) together with people living with HIV will this Thursday, July 4, 2019, march and petition parliament over the obtaining shortage of Anteretroviral (ARVs) drugs and drug stock outs. The march is being organised by Zimbabwe Aids Network (ZAN), Zimbabwe Positive Youths (ZY+), Zimbabwe National Network of People Living with HIV (ZNNP+) and will see various other pressure groups aligned to the HIV cause joining in.

Share
Read More

‘Cyclone Idai Destroyed ARVs For Over 1 million People’

ABOUT 1 , 1 million people living with HIV were left stranded without access to antiretroviral medication in the Cyclone Idai distressed countries, a top United Nations official said on Monday. By Kudakwashe Pembere Briefing the media, UN Assistant Secretary General for Humanitarian Affairs and Deputy Emergency Relief Coordinator Ursula Mueller said they were concerned about people in Malawi, Mozambique and Zimbabwe living with HIV who lost their medication. “The imminent loss of antiretroviral medication to some 1, 1 million people is particularly alarming,” she said. She also bemoaned the…

Share
Read More

RBZ Ignores Looming ARV Crisis

THE Reserve Bank of Zimbabwe’s reluctance to release the much needed US$6 million by the National Aids Council of Zimbabwe (NAC) could plunge the nation into Antiretroviral shortage imminently. By Kudakwashe Pembere This was said by the CCM Coordinator Mr Oscar Mundida at a Civil Society Organisation workshop on Universal Health Coverage organized by UNAIDS and Zimbabwe Aids Network. Mr Mundida said NAC is yet to get their hands on the US$6 million to settle arrears they owe to ARV suppliers. The CCM Coordinator explained that Zimbabwe has nothing to…

Share
Read More

People Living With HIV Worried Over Expired ARVs…MCAZ Calls For Calm

PEOPLE living with HIV (PLHIV) have expressed concerns over failure by government and the Medicines Control Authority of Zimbabwe (MCAZ) to consult with them following the expiration of Antiretroviral (ARV) drugs. By Michael Gwarisa The development follows revelations that health institutions continued dispensing ARVs even after they had passed their shelf life. This has not  gone down well with PLHIV and on ART who  believe the consultation process should have started with them since they are the ones directly affected by any changes in the drugs. Speaking to HealthTimes, Mrs…

Share
Read More